Evaluation of Vitamin B12 Monitoring in Patients on Concomitant Metformin and Proton Pump Inhibitors

BACKGROUND: Type 2 diabetes mellitus and gastroesophageal reflux disease are highly prevalent in the United States. First-line therapies for these disease states include metformin and proton pump inhibitors, respectively. Both of these medications have been associated with a decreased absorption of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chappell, Logan, Brown, Stephen A., Wensel, Terri M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127105/
https://www.ncbi.nlm.nih.gov/pubmed/34007643
http://dx.doi.org/10.24926/iip.v11i4.3355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127105/
https://www.ncbi.nlm.nih.gov/pubmed/34007643
http://dx.doi.org/10.24926/iip.v11i4.3355

Ejemplares similares